Dopamine antagonists for the treatment of drug addiction: PF-4363467 and related compounds

Abstract

Drug addiction refers to an out-of-control and compulsive use of substances, which can reach epidemic magnitudes. It is a health concern throughout the world and has major economic impact. Dopamine receptor agonists and antagonists have been cited as molecular targets for the treatment of drug addiction. In this report, the main idea is to analyze the new D3R/D2R ligands that are proposed for the treatment of drug abuse, in terms of their electron donor/acceptor properties. Substances catalogued as agonists represent good electron donors, whereas antagonists represent good electron acceptors. HOMO and LUMO eigenvalues indicate that more energy is necessary to remove an electron from the antagonists, and likewise more energy is gained when antagonists accept an electron. The combination of two molecules (PF-592379 and PNU-177864) produces a new compound (PF-4363467) with properties that are intermediate. Irrespective of the characteristics of the receptor, the classification of ligands is important, in order to further understanding of the reaction mechanism of these compounds. This may help in the design of new molecules for the treatment of drug addiction.

Electron Donor–Acceptor Properties of Different Muscarinic Ligands: On the Road to Control Schizophrenia

“…With these parameters, it is possible to determine the electron donor–acceptor MAP (DAM) (see Figure ). These chemical descriptors have been used successfully in many different chemical systems. ,− …”

New information of dopaminergic agents based on quantum chemistry calculations

“…Previous reports 45 – 47 have used quantum chemistry calculations to help describe the pharmacodynamics of antipsychotic drugs, relating biological activity to chemical reactivity indices, such as chemical hardness and first ionization energy. There is also a comparative study of 32 oral antipsychotics used for treatment of schizophrenia (3 partial agonists and 29 antagonists) recently published 48 .…”

Interaction of graphene with antipsychotic drugs: Is there any charge transfer process?

“…One of the working hypotheses is that there is a charge transfer process between the drugs and the receptors, which is different for agonists and antagonists. [32][33][34] There is also a physical model wherein a membrane is used to detect modifications on the electrical potential due to the presence of these drugs. The membrane noise produced by a polarizing drug is interpreted as a change in the electrical potential of the system.…”

“…Briefly, it can be said that antagonists of dopamine are molecules that interact but do not activate the receptor while agonists are those that bind and activate the receptor, as dopamine does. One of the working hypotheses is that there is a charge transfer process between the drugs and the receptors, which is different for agonists and antagonists 32–34 . There is also a physical model wherein a membrane is used to detect modifications on the electrical potential due to the presence of these drugs.…”